Cargando…
Impact of Short-Acting Disopyramide on Left Ventricular Mechanics Evaluated by Strain Analysis in Patients with Hypertrophic Obstructive Cardiomyopathy
Background: Disopyramide is a class Ia antiarrhythmic drug that has been used for the second-line treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of the study was to assess the impact of short-acting disopyramide in patients with hypertrophic obstructive cardiomyopat...
Autores principales: | Yedidya, Idit, Elbaz Greener, Gabby, Vaturi, Mordehay, Sagie, Alik, Amir, Offer, Carasso, Shemy, Monakier, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785974/ https://www.ncbi.nlm.nih.gov/pubmed/36555940 http://dx.doi.org/10.3390/jcm11247325 |
Ejemplares similares
-
Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019) -
The Battle against Cardiogenic Shock
por: Rahamim, Eldad, et al.
Publicado: (2022) -
Left atrial phasic echocardiographic functional analysis in relation to diastolic left ventricular hemodynamic parameters acquired during right heart catheterization
por: Rinot, Ephraim, et al.
Publicado: (2022) -
Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020) -
Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients
por: Adler, Arnon, et al.
Publicado: (2017)